Cite

HARVARD Citation

    Gaye, E. et al. (2019). Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis. Lung cancer. pp. 1-3. [Online]. 
  
Back to record